BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7585622)

  • 1. Human homologue of a candidate for the Mom1 locus, the secretory type II phospholipase A2 (PLA2S-II), maps to 1p35-36.1/D1S199.
    Praml C; Savelyeva L; Le Paslier D; Siracusa LD; Buchberg AM; Schwab M; Amler LC
    Cancer Res; 1995 Dec; 55(23):5504-6. PubMed ID: 7585622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.
    MacPhee M; Chepenik KP; Liddell RA; Nelson KK; Siracusa LD; Buchberg AM
    Cell; 1995 Jun; 81(6):957-66. PubMed ID: 7781071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the secretory phospholipase A2 gene, a candidate of Mom1 gene, in neuroblastomas.
    Kawamata N; Seriu T; Bartram CR; Koeffler HP
    Cancer Lett; 1997 Jan; 111(1-2):71-5. PubMed ID: 9022130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours.
    Tomlinson IP; Beck NE; Neale K; Bodmer WF
    Ann Hum Genet; 1996 Sep; 60(5):369-76. PubMed ID: 8912789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa.
    Praml C; Amler LC; Dihlmann S; Finke LH; Schlag P; Schwab M
    Oncogene; 1998 Oct; 17(15):2009-12. PubMed ID: 9788445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36.
    Tomlinson IP; Neale K; Talbot IC; Spigelman AD; Williams CB; Phillips RK; Bodmer WF
    J Med Genet; 1996 Apr; 33(4):268-73. PubMed ID: 8730279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis.
    Cormier RT; Hong KH; Halberg RB; Hawkins TL; Richardson P; Mulherkar R; Dove WF; Lander ES
    Nat Genet; 1997 Sep; 17(1):88-91. PubMed ID: 9288104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
    Silverman KA; Koratkar R; Siracusa LD; Buchberg AM
    Genome Res; 2002 Jan; 12(1):88-97. PubMed ID: 11779834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis.
    Koratkar R; Silverman KA; Pequignot E; Hauck WW; Buchberg AM; Siracusa LD
    Genomics; 2004 Nov; 84(5):844-52. PubMed ID: 15475263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three secretory phospholipase A(2) genes that map to human chromosome 1P35-36 are not mutated in individuals with attenuated adenomatous polyposis coli.
    Spirio LN; Kutchera W; Winstead MV; Pearson B; Kaplan C; Robertson M; Lawrence E; Burt RW; Tischfield JA; Leppert MF; Prescott SM; White R
    Cancer Res; 1996 Mar; 56(5):955-8. PubMed ID: 8640784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.
    Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR
    Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of secretory phospholipase A2 gene alterations in human colorectal cancer.
    Riggins GJ; Markowitz S; Wilson JK; Vogelstein B; Kinzler KW
    Cancer Res; 1995 Nov; 55(22):5184-6. PubMed ID: 7585570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines.
    Haluska FG; Thiele C; Goldstein A; Tsao H; Benoit EP; Housman D
    Int J Cancer; 1997 Jul; 72(2):337-9. PubMed ID: 9219842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of frequent involvement of modifier of Min(APC) in sporadic colorectal cancer.
    Kahlenberg MS; Stoler DL; Petrelli NJ; Rodriguez-Bigas M; Weber TK; Anderson GR
    Ann Surg Oncol; 1998 Mar; 5(2):181-5. PubMed ID: 9527272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusion of an extracolonic disease modifier locus on chromosome 1p33-36 in a large Swiss familial adenomatous polyposis kindred.
    Plasilova M; Russell AM; Wanner A; Wolf A; Dobbie Z; Müller HJ; Heinimann K
    Eur J Hum Genet; 2004 May; 12(5):365-71. PubMed ID: 14735163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Mom1 modifier of intestinal neoplasia in mice.
    Gould KA; Dove WF
    Exp Lung Res; 1998; 24(4):437-53. PubMed ID: 9659576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPLASH (PLA2IID), a novel member of phospholipase A2 family, is associated with lymphotoxin deficiency.
    Shakhov AN; Rubtsov AV; Lyakhov IG; Tumanov AV; Nedospasov SA
    Genes Immun; 2000 Feb; 1(3):191-9. PubMed ID: 11196711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated expansion of group IID-like phospholipase A2 genes in Bos taurus.
    Golik M; Cohen-Zinder M; Loor JJ; Drackley JK; Band MR; Lewin HA; Weller JI; Ron M; Seroussi E
    Genomics; 2006 Apr; 87(4):527-33. PubMed ID: 16469480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers.
    Tay A; Simon JS; Squire J; Hamel K; Jacob HJ; Skorecki K
    Genomics; 1995 Mar; 26(1):138-41. PubMed ID: 7782073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis.
    Dobbie Z; Müller H; Scott RJ
    Hum Genet; 1996 Sep; 98(3):386-90. PubMed ID: 8707313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.